A celiac disease test measures antibodies associated with the body's immune response to gluten-related proteins, rather than confirming celiac disease on its own. Shoppers often compare tTG IgA with total IgA, deamidated gliadin peptide antibodies, and endomysial IgA because each result answers a slightly different screening question. Total IgA helps place an IgA antibody result in perspective, while IgG testing offers another antibody type. Start by deciding whether you need a single tTG IgA measurement, deamidated gliadin IgA and IgG results, or a panel that includes total IgA.
How celiac-related antibody tests differ
Tissue transglutaminase (tTG) IgA measures an IgA antibody directed at tissue transglutaminase and is commonly used in celiac-related screening. Total IgA measures the overall amount of immunoglobulin A, helping put a tTG IgA result in perspective when IgA levels are lower than expected. Deamidated gliadin peptide (DGP) IgA and IgG measure antibodies to deamidated gliadin peptides; reporting both antibody classes provides separate IgA and IgG results. Endomysial IgA screening measures another celiac-associated antibody and includes reflex to a titer when the screen is positive. These blood results require clinical interpretation and do not establish a diagnosis by themselves.
Using results thoughtfully
An antibody result is most useful when considered with symptoms, medical history, and the reason for testing. A tTG IgA result without total IgA does not show whether the body's overall IgA level could affect interpretation. DGP IgG supplies an IgG-based result, which differs from an IgA-only measurement. Endomysial IgA screening with reflex to titer first reports a screen and then provides a titer if that screen is positive. Results can be negative or positive for reasons that need professional review, so ongoing digestive symptoms or a concerning result warrants discussion with a qualified clinician.